Efficacy and tolerability of once-weekly administration of 17.5mg risedronate in Japanese patients with involutional osteoporosis : a comparison with 2.5-mg once-daily dosage regimen

8 Citations 22 References

KISHIMOTO Hideaki

Department of Orthopedics, San-in Rosai Hospital
FUKUNAGA Masao

Department of Nuclear Medicine, Kawasaki Medical School
KUSHIDA Kazuhiro

Department of Orthopedics, Hamamatsu University School of Medicine
SHIRAKI Masataka

Research Institute and Practice for Involutional Diseases
ITABASHI Akira

Department of Clinical Laboratory Medicine, Saitama Medical School
NAWATA Hajime

Department of Internal Medicine, Faculty of Medicine, Kyushu University
NAKAMURA Toshitaka

Department of Orthopedics, University of Occupational and Environmental Health
OHTA Hiroaki

Department of Obstetrics and Gynecology, Tokyo Women's Medical University
TAKAOKA Kunio

Department of Orthopedics, Osaka City University School of Medicine
OHASHI Yasuo

Biostatistics/Epidemiology and Preventive Health Sciences, School of Health Sciences and Nursing, University of Tokyo

Search this article